Cargando…
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer
Pancreatic cancer is a highly aggressive malignancy with a climbing incidence. The majority of cases are detected late, with incurable locally advanced or metastatic disease. Even in individuals who undergo resection, recurrence is unfortunately very common. There is no universally accepted screenin...
Autores principales: | Raufi, Alexander G., May, Michael S., Hadfield, Matthew J., Seyhan, Attila A., El-Deiry, Wafik S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958987/ https://www.ncbi.nlm.nih.gov/pubmed/36835649 http://dx.doi.org/10.3390/ijms24044238 |
Ejemplares similares
-
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021) -
Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
por: Zhang, Shengliang, et al.
Publicado: (2022) -
Targeting the Integrated Stress Response in Cancer Therapy
por: Tian, Xiaobing, et al.
Publicado: (2021) -
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021) -
Are we losing the war on cancer?
por: El-Deiry, Wafik S
Publicado: (2013)